Lakrimont (Carbomer)

Carbomer absorbs water and swells to form a clear, gel‑like matrix. This matrix creates a protective film over the tear layer, slowing evaporation and enhancing moisture retention. The increased viscosity also helps other active ingredients stay longer on the eye, improving their effectiveness.

The dose of Lakrimont is determined by the prescribing eye‑care professional based on the patient’s condition and response. Typical regimens involve one to two drops per eye, but the exact amount and frequency should follow the prescriber’s instructions.

Limited clinical data are available on the use of carbomer‑based ocular products during pregnancy or lactation. Healthcare providers should weigh the potential benefits against any unknown risks and consider alternative treatments if safety cannot be assured.

To request Lakrimont, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lakrimont’s carbomer base offers a high‑viscosity gel that can provide longer‑lasting lubrication compared with solutions based on sodium hyaluronate or polyethylene glycol. However, individual tolerance varies, and some patients may prefer lower‑viscosity drops for rapid comfort. Choice depends on the severity of dryness and clinician preference.

Lakrimont should be stored at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture, direct sunlight and extreme temperature fluctuations. Do not freeze the product, and avoid contaminating the dropper tip during use.

Lakrimont is applied topically to the eye. The recommended method is to tilt the head back slightly, pull down the lower eyelid, and instill the prescribed number of drops into the conjunctival sac. Avoid touching the dropper tip to the eye or any surface.

The most serious adverse events include allergic reactions such as swelling, itching or rash, and rare cases of corneal ulceration that can threaten vision. If any severe eye pain, persistent redness, vision changes, or signs of infection develop, discontinue use and seek immediate medical attention.

Lakrimont should be avoided in patients with a known hypersensitivity to carbomer or any component of the formulation. It is also not recommended for individuals with active ocular infections, severe inflammation, or those who have recently undergone eye surgery unless directed by an eye‑care professional.